ETF profile for Global X Genomics & Biotechnology ETF (GNOM) from the issuer: top holdings, net assets, expense ratio and shares outstanding.
GNOM ETF Profile
| Family: |
Global X |
| Name: |
Global X Genomics & Biotechnology ETF |
|
|
| Inception Date: |
5-Apr-2019 |
| Termination Date: |
|
| Investment Objective: |
The Global X Genomics & Biotechnology ETF (GNOM) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Solactive Genomics Index. The Solactive Genomics Index tracks the price movements in shares of companies which are active in the field of Genomics. These companies include those involved in the following business activities: gene editing, genomic sequencing, development and testing of genetic medicine or therapies, computational genomics and genetic diagnostics or biotechnology. |
|
|
| Prospectus |
|
|
|
| Top 10 Holdings |
|
|
| MODERNA INC |
MRNA |
12.1700% |
| TWIST BIOSCIENCE CORP |
TWST |
6.3500% |
| 10X GENOMICS INC-CLASS A |
TXG |
6.1200% |
| ILLUMINA INC |
ILMN |
5.8800% |
| NATERA INC |
NTRA |
5.5800% |
| GUARDANT HEALTH INC |
GH |
5.3000% |
| BIO-TECHNE CORP |
TECH |
3.5500% |
| GENSCRIPT BIOTECH CORP |
1548 |
3.4200% |
| VERTEX PHARMACEUTICALS INC |
VRTX |
3.3300% |
| QIAGEN N.V. |
QGEN |
3.3100% |
|
Top 10 Holdings Weight: |
55.0% |
| Number of Holdings: |
52 |
| Shares Outstanding: |
1,604,672 |
| Total Net Assets: |
107,529,072 |
| NAV: |
66.87 |
| Net Expense Ratio: |
0.50% |
|
|
| Asset Class: |
Equities (Stocks) |
| Developed or Emerging: |
Developed Market Funds |
| Country: |
|
| Region: |
|
| Strategy: |
|
| Currency: |
|
| Commodity: |
|
| Sector: |
Healthcare |
| Industry: |
Biotech |
| Dividend Type: |
|
| Tax Exempt State: |
|
| Maturity Duration: |
|
| Market Cap: |
Broad Market / Multi-Cap |
| Credit Quality: |
|
| Mortgage Bond Types: |
|
| Bond Type: |
|
| Gov't Bond Types: |
|
| Reit Type: |
|
| Leverage Direction/Factor: |
|
| Is Currency Hedged: |
No |
| US or Ex-US: |
Global |
